REBECCA GEIGER: Open Payments
NPI 1396847406 · LEHIGHTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 17 payments from 8 companies in 2025. Trend: 2023 $4,486 · 2024 $1,983 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 4 | $180 |
| ABBVIE INC. | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Galderma Laboratories, L.P. | 3 | $60 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| UCB, Inc. | 1 | $15 |
Products named: NOVACHOR, SKYRIZI, DUPIXENT, PURAPLY WOUND MATRIX, ILUMYA, CYGNUS DUAL, COSENTYX, OTEZLA.
Industry payments across PA — which companies pay providers there.
